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Antibodies to Middle East respiratory syndrome coro-
navirus (MERS-CoV) were detected in serum and milk 
collected according to local customs from 33 camels in 
Qatar, April 2014. At one location, evidence for active 
virus shedding in nasal secretions and/or faeces was 
observed for 7/12 camels; viral RNA was detected in 
milk of five of these seven camels. The presence of 
MERS-CoV RNA in milk of camels actively shedding 
the virus warrants measures to prevent putative food-
borne transmission of MERS-CoV.
In April 2014, serum, nasal swabs and rectal swabs 
were taken from 33 milking dromedary camels at two 
locations in Qatar (Al Shahaniya and Dukhan), areas 
with known Middle East respiratory syndrome corona-
virus (MERS-CoV) circulation in camels [1] and data not 
shown. In addition, milk was collected from these ani-
mals according to local customs. Serum samples and 
milk were tested for the presence of MERS-CoV-specific 
antibodies by protein microarray, with confirmation by 
virus neutralisation. Swabs and milk were tested for the 
presence of MERS-CoV RNA by real-time reverse tran-
scription (RT)-PCR testing for multiple genomic targets. 
Antibodies to MERS-CoV were detected in serum and 
milk from all camels at both locations. At the Dukhan 
location, none of the 21 animals tested was actively 
shedding viral RNA from the nose and/or in faeces and 
no evidence for the presence of MERS-CoV RNA in milk 
was observed. At the Al Shahaniya location, evidence 
for active virus shedding was observed for seven of the 
12 camels tested. Viral RNA was detected in milk of five 
of the seven camels with active virus shedding.
Background
In 2012, MERS-CoV was identified in patients with 
severe respiratory illness in the Middle East [2]. As of 
11 June 2014, a total of 683 cases including 204 deaths 
have been reported to the World Health Organization 
(WHO) [3]. All cases have had an epidemiological 
link to the Middle East, with confirmed cases in Iran, 
Jordan, Kuwait, Lebanon, Oman, Saudi Arabia, Qatar, 
United Arab Emirates and Yemen. Human-to-human 
transmission seems limited to family and healthcare 
settings and is assumed to have contributed to the 
recent upsurge of cases [4]. Overall, however, a large 
proportion of cases of MERS-CoV infection is commu-
nity acquired, with suspected zoonotic transmission, 
although the extent thereof remains to be determined 
[5]. Dromedary camels (Camelus dromedarius) are the 
prime suspects to serve as an animal reservoir for 
MERS-CoV, although alternative sources remain pos-
sible [6-11].
In August 2013, dromedary camels were implicated for 
the first time as a possible source of the virus leading to 
human infection on the basis of the presence of MERS-
CoV neutralising antibodies in dromedaries from Oman 
and the Canary Islands of Spain [6]. Since then, MERS-
CoV-specific antibodies have been detected in camels 
across the Middle East and in several African countries 
[7-9]. Analysis of an outbreak of MERS-CoV infection 
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in humans associated with a barn in Qatar in October 
2013 found dromedaries and humans to be infected 
with nearly identical strains of MERS-CoV [1] and the 
virus was isolated from dromedaries shortly after [10]. 
Further support for camels as a reservoir came from a 
study in Saudi Arabia that found widespread circula-
tion of different genetic variants of MERS-CoV in cam-
els, and antibodies in samples taken since the early 
90s [11].
Although camels are suspected to be the primary 
source of MERS-CoV leading to human infection, the 
routes of direct or indirect zoonotic transmission 
remain unknown. A possible route might be food-borne 
transmission through consumption of raw camel milk 
or undercooked meat. Here we report on our investiga-
tions into virus shedding of milking camels, in relation 
to the presence of MERS-CoV RNA in milk, as a first 
assessment of a potential role of consumption of raw 
camel milk in MERS-CoV transmission.
Analysis of dromedary serum, milk, nasal 
and rectal swabs
Sample collection
In April 2014, serum, nasal swabs, rectal swabs and 
milk were collected from 12 dromedary camels in three 
barns at the Al Shahaniya barn complex and 21 drom-
edary camels from a milking herd in the Dukhan area, 
Qatar. The milking camels at the barns at Al Shahaniya 
were kept together with racing camels that have reg-
ular contact with camels outside the barn at practice 
and racing events. Barn 1 held 22 racing and nine milk-
ing camels. Barn 2 held 18 racing and four milking 
camels, while Barn 3 held 15 racing and three milking 
camels. Each milking camel (dam) had their calf pre-
sent. The age range of the calves was three to eight 
months (Table).
The herd in the Dukhan area was in a secluded area 
far from other animals. The age range of the calves 
was three to seven months. Both locations had known 
circulation of MERS-CoV in dromedaries at the end of 
2013/beginning of 2014 [1] and data not shown.
Table 
Middle East respiratory syndrome coronavirus (MERS-CoV) analysis of serum, nasal and rectal swabs and milk of dairy 




























d Milkd Serume Milke
1
1 8 3 – – – – – – – + + ≥1,280 80
2 7 4 + – + – – – + + + 640 Eq.
3 10 4 – + – – – – – + + ≥1,280 80
4 8 5 + – – – – – – + + ≥1,280 Eq.
5 7 6 + + + – + + + + + ≥1,280 40
6 9 7 + – + – + + + + + ≥1,280 40
7 9 7 + – + – + + + + + ≥1,280 40
2
8 10 5 – + + – + + + + + ≥1,280 40
9 8 3 – – – – – – – + + ≥1,280 40
3
10 15 8 – – – – – – – + + ≥1,280 NT
11 12 5 – – – – – – – + + ≥1,280 20




NA NA NA 5 3 5 0 4 4 5 12 12 12 9 
Eq.: equivocal (titre between ≥5 and <20); NA: not applicable; NT: not tested due to lack of sample.
A dash represents that the test was negative.
a  A dam is the femal parent of a livestock animal.
b  A sample is considered PCR positive for MERS-CoV when >2 targets (UpE, Orf1a and/or N) are reactive. 
c  Summary results of whole milk, milk fat, skimmed milk and cell pellet.
d  Serology based on MERS-CoV S1 protein-microarray. Cut-off value 4,000 relative mean fluorescent intensity.
e  Serology based on MERS-CoV neutralisation assay. Starting dilution 1:5. Neutralising antibody titres are shown.
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No samples were collected from the calves. Serum 
and swabs from the dams were collected wearing a 
disposable gown, gloves, goggles and FFP2 mask, as 
described [1]. Milk was collected according to local cus-
toms as follows: dromedary calves were not weaned 
after delivery but kept at the farm in paddocks adja-
cent to their dams throughout lactation. Dams were 
reunited with their calf to trigger milk production. 
Once milk production was initiated, the milk samples 
were collected by the camel owner or handler accord-
ing to regional customs. No specific hygienic precau-
tions were taken (Figure). All samples were stored at 
−80°C until shipment to the Netherlands on dry ice. All 
sera and swabs were shipped in agreement with Dutch 
import regulations for animal samples from foot-and-
mouth disease-endemic regions and stored and han-
dled in a biosafety level 3 laboratory until inactivation 
by incubation for 4 hours at 56 °C or addition of lysis 
buffer, respectively.
Sample testing
Total nucleic acids from swabs were isolated using an 
automated MagNAPure 96 extraction with the total 
nucleic acid isolation kit (Roche, Mannheim, Germany). 
Swabs were tested for MERS-CoV RNA by internally 
controlled real-time RT-PCR targeting UpE and N genes, 
as described [1,12]. Initial observations of reduced 
nucleic acid recovery when whole milk was extracted 
using routine protocols for clinical samples triggered 
us to test milk fractions, besides whole milk, for puta-
tive increase of sensitivity [13,14]. Total RNA was manu-
ally extracted from whole milk, skimmed milk, cellular 
pellet and cream components of milk samples using 
the High Pure RNA isolation kit (Roche, Mannheim, 
Germany). Extracts of whole milk and milk fractions 
were tested for MERS-CoV RNA by internally controlled 
real-time RT-PCR targeting Orf1A and UpE genes, as 
described [1, 12]. According to international consensus, 
samples were considered positive for MERS-CoV RNA 
when at least two different targets were reactive [15].
At Al Shahaniya, seven of the 12 camels tested were 
actively shedding viral RNA from the nose (n=5) and/
or faeces (n=3) with threshold cycle (Ct) values rang-
ing between 23.0 and 29.7. Overall, milk obtained from 
five of the seven virus-shedding animals demonstrated 
presence of MERS-CoV RNA (Table) with Ct values rang-
ing from 29.2 to 37.9. Sequence analysis of the PCR 
products from the milk fraction with the highest viral 
load confirmed the presence of MERS-CoV (data not 
shown).
At the Dukhan location, none of the 21 animals tested 
was actively shedding viral RNA and no evidence for 
the presence of MERS-CoV RNA in milk was obtained 
(data not shown). Milk fractions of bulk milk collected 
from dairy dromedaries in the Netherlands tested neg-
ative for MERS-CoV RNA (data not shown).
Serum and milk samples were tested for the presence 
of IgG antibodies reacting with MERS-CoV (residues 
1–747), severe acute respiratory syndrome (SARS)-CoV 
(residues 1–676) and human coronavirus (HCoV)-OC43 
(residues 1–760) spike domain S1 antigens using exten-
sively validated protein-microarray technology, as 
described [6,16-18]. HCoV-OC43 S1 was used as proxy 
for bovine CoV (BCoV), which is known to circulate com-
monly in dromedaries [19,20]. All serum and milk sam-
ples from Al Shahaniya and the Dukhan location had 
MERS-CoV S1 binding antibodies (Table and data not 
shown).
Figure
Milking camels according to local customs, Al Shahaniya barn complex, Qatar, April 2014
Milk production is triggered by the calf: the calf is then set aside and the milk is collected. 
Photographs by E. Farag.
4 www.eurosurveillance.org
Confirmation of array results from Al Shahaniya was 
done by MERS-CoV neutralisation assays, as described 
[6]. Neutralising antibody titres varied between 640 
and ≥1,280 for serum and between 10 and 80 for milk 
with 9 out of 11 having titres fourfold above the start-
ing dilution of 1:5 (Table). Control serum (n=3) and 
bulk milk collected from dairy dromedaries in the 
Netherlands were negative (data not shown). All serum 
and milk samples from both locations in Qatar and the 
Netherlands reacted with HCoV-OC43 S1 confirming 
common circulation of BCoV in camelids. All samples 
tested negative for SARS-CoV (data not shown).
To gain insight into possible faecal contamination of the 
milk samples, the samples were analysed for the pres-
ence of Escherichia coli by a quantitative PCR based on 
the E. coli uidA gene, with a limit of quantification of 
<103 genome copies per ml [21]. The presence of E. coli 
was not consistently detected in repeated testing (data 
not shown).
Discussion
Raw milk from dromedaries has been consumed by 
humans for thousands of years and is thought to have 
healing properties when consumed ‘hot’, directly out 
of the udder [22]. Nowadays, dromedaries are still an 
important source of milk in rural areas of arid countries 
such as Qatar and other countries in the Middle East 
and parts of Africa [23]. Food-borne transmission is a 
putative route of zoonotic transmission of MERS-CoV 
that needs further investigation. Recent data demon-
strated that MERS-CoV experimentally introduced into 
camel milk can survive for up to 72 hours at 4 °C and 
22 °C and it has been suggested that consumption of 
MERS-CoV-containing milk might result in introduction 
of the virus into the oral cavity and subsequent infec-
tion of the lower respiratory tract [24].
Here, we detected the presence of MERS-CoV RNA 
in five milk samples collected from seven animals 
shedding MERS-CoV from the nose and/or feces at Al 
Shahaniya. Although shedding of infectious virus in 
ruminant milk and infection of humans due to the con-
sumption of raw milk have been described for several 
viruses [25,26], it cannot be concluded from our data 
that this holds true for MERS-CoV as well. The milk 
samples were collected according to local customs in 
which camel udders are not normally cleaned before 
milking and hygienic conditions are such that udders 
and milk can be contaminated with nasal secretions or 
faeces from the camel, saliva of the calves, which are 
allowed to suckle prior to milking to initiate the milk 
flow, or dirt from the bowl or the hands of the milker. 
Additional studies under controlled hygienic conditions 
are ongoing to determine whether MERS-CoV replicates 
in the udder or could be introduced as contaminant 
during the milking process.
It remains to be seen if the results reflect the pres-
ence of infectious virus in the milk samples. The RNA 
loads in the milk samples were too low to attempt virus 
isolation; we have observed that samples containing 
MERS-CoV RNA with Ct values >30 in general do not 
contain infectious virus particles. Experiments aiming 
at determining the amount of infectious virus present 
in milk samples such as those collected in our study 
should be conducted locally, avoiding detrimental 
effects of shipment and freeze-thaw cycles on virus via-
bility. In addition, the presence of substantial levels of 
MERS-CoV neutralising antibodies in the milk samples 
might neutralise any infectious virus present during in 
vitro testing, which may differ from the in vivo situa-
tion, particularly if the virus is resistant to gastric juice 
and passage of infectious virus through the stomach 
occurs [27]. Nevertheless, it can be concluded that the 
presence of MERS-CoV RNA in raw milk as consumed 
locally might represent a source for zoonotic transmis-
sion of MERS-CoV and prudence is called for. Munster 
et al. showed that heat treatment (30 minutes at 63 °C) 
of MERS-CoV-containing camel milk reduced levels of 
infectious virus below detection level [24]. Boiling milk 
before consumption could be an easy, achievable local 
measure to prevent transmission and to preserve con-
sumption of camel milk.
An interesting observation is the difference in virus 
shedding between the herds at Al Shahaniya and 
Dukhan (7/12 and 0/21, respectively) although virus cir-
culation had been detected in the Dukhan location ear-
lier (data not shown). While the current study provides 
only a snapshot, it suggests that herd management 
practices may influence virus circulation. In addition, 
the nasal and/or faecal shedding of MERS-CoV by ani-
mals with high levels of neutralising antibodies sug-
gests that the presence of antibodies does not confer 
sterilising immunity.
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